Theoloxin en es it fr

Theoloxin Brand names, Theoloxin Analogs

Theoloxin Brand Names Mixture

  • No information avaliable

Theoloxin Chemical_Formula


Theoloxin RX_link

No information avaliable

Theoloxin fda sheet

Theoloxin msds (material safety sheet)

Theoloxin MSDS

Theoloxin Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Theoloxin Molecular Weight

232.235 g/mol

Theoloxin Melting Point

174 oC

Theoloxin H2O Solubility

<0.01 g/100 mL

Theoloxin State


Theoloxin LogP


Theoloxin Dosage Forms

Tablet; Elixir

Theoloxin Indication

For the treatment of Epilepsy

Theoloxin Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Theoloxin Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Theoloxin side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Theoloxin Patient Information


Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS

Theoloxin Organisms Affected

Humans and other mammals